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Introduction
An important role of tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine, in the pathogenesis of airway inflammatory diseases such as allergic asthma has been extensively documented [1] [2] [3] [4] [5] . TNFα was detected in bronchoalveolar lavage fluid, exhaled breath condensate and sputum of asthmatic patients during acute exacerbation or after antigen inhalation challenge in these patients [6, 7] . TNFα is released from a variety of cell types in the airways, such as mast cells and macrophages, via the immunoglobulin Edependent mechanism [2, 5, 8, 9] . Once released, TNFα can exert multiple effects on a number of effector cells and induce the inflammatory reaction in the airways. Inhalation of aerosolized TNFα induced bronchial hyperresponsiveness accompanied by airway inflammation in healthy human subjects [10] , but the underlying mechanism was not fully understood. One of the prominent pathophysiological features of inflammation-induced bronchial hyperresponsiveness is a heightened sensitivity of airway sensory nerves [11, 12] .
Previous investigators have repeatedly reported that TNFα induced a potent sensitizing effect on dorsal root ganglion (DRG) and trigeminal ganglion nociceptive neurons, leading to the development of lingering inflammatory pain in various somatic tissues [13] [14] [15] [16] . This hyperalgesic effect was mediated through an action on the TNF receptors, TNFR1 and TNFR2, located on the cell surface, which resulted in an increase in the sensitivity and/or expression of transient receptor potential vanilloid type 1 (TRPV1) receptors expressed in these nociceptive neurons [3] . For example, in isolated DRG neurons, pretreatment with TNFα for a short-duration (60 s) immediately and reversibly increased the current amplitude evoked by activation of TRPV1 receptors, and this rapid and transient sensitizing effect of TNFα was attenuated by deletion of the TNFR2 gene [17] . On the other hand, exposure of DRG neurons to TNFα for a longer duration (48 hours) induced a pronounced increase in the proportion of DRG neurones expressing TRPV1 receptor-like immunoreactivity [18] . Interestingly, the TNFα-induced TRPV1 expression was clearly increased in the mediumand large-size neurons that normally do not exhibit TRPV1 sensitivity; and this effect of TNFα was absent in the DRG neurons isolated from mice lacking TNFR1 [18] .
The C-fiber sensory nerves are the dominant subtype of vagal afferents innervating the entire respiratory tract in various mammalian species including mice [19] [20] [21] . Increasing evidence suggests that activation of these bronchopulmonary C-fiber afferents is responsible for the manifestation of various symptoms in the airway inflammatory diseases [11, 12] . An abundant expression of TRPV1 in the neuronal soma and sensory terminals is a reliable and prominent biomarker of these C-fiber afferents [22, 23] . More importantly, recent studies have shown that chronic airway inflammation upregulated the sensitivity and expression of TRPV1 in these sensory nerves innervating the airways and lungs [24, 25] .
In the light of these previous findings, we recently carried out a series of studies aimed to investigate if airway delivery of TNFα induced airway inflammation and elevated the TRPV1 sensitivity of bronchopulmonary sensory nerves; and if so, whether the sensitizing effect of TNFα was mediated through its action on TNFRs. Mouse was chosen as the animal species for these studies so that the involvement of TNFRs could be evaluated in TNFreceptor double homozygous mutant mice (TNF −/− ). Experimental methods, protocols and results of these studies have been reported in details in our recent publications [26] [27] [28] , and a collected summary of this series of studies is presented in this mini-review.
Airway inflammation induced by TNFα
TNFα released from mast cells, macrophages and other inflammatory cells can trigger diverse and potent inflammatory responses in the airways. Activation of TNFRs by TNFα can cause a chemotactic action, upregulate the leukocyte-endothelial cell adhesive molecules E-selectin and vascular cell adhesion molecule-1, which in turn can enhance the production of Th2 cytokines and cause infiltration and degranulation of these inflammatory cells such as neutrophils and eosinophils in the airways [5, 10, 29, 30] . These diverse actions of TNFα can further enhance the release of various pro-inflammatory/chemotactic mediators [5, 29] . We carried out this study to determine whether airway inflammation is induced by TNFα treatment in our mouse model, and if so, if this effect is mediated through the action of TNFα on TNFRs. The experiments were carried out in two groups of young male mice: wild-type (WT; B6129SF2/J) and TNF −/− mice (129S-Tnfrsf1a tm1Imx Tnfrsf1b tm1Imx /J) in which both types of TNF receptors, TNFR1 and TNFR2, were mutated.
The animal preparation and experimental methods were described in details by Lin et al [27] . Briefly, after mice were anesthetized by isoflurane inhalation, a small (~0.5 cm) midline incision was made on the ventral neck skin to expose the trachea. Under sterile condition, TNFα solution (10 µg/ml; 0.03 ml) and its vehicle (Veh; phosphate buffered saline, 0.03 ml) were instilled into the trachea via a needle (28-gauge) in treated (TNFα) and control (Veh) mice, respectively; the incision was then closed. Twenty-four hours (unless noted otherwise) later, bronchoalveolar lavage fluid (BALF) was obtained for measurements of inflammatory cells and mediators from five groups of mice: 1) Naïve group (WT mice receiving no surgery or treatment); 2) Veh group (WT mice treated with Veh); 3) & 4): TNFα 1 and 7 days groups (WT mice 1 and 7 days after treatment with TNFα); and 5) TNF −/− +TNFα group (TNF −/− mice treated with TNFα).
BALF samples were obtained from 5 mice in each group for the differential cell count, except n=7 in the TNFα (7 days) group. Results showed that the total number of leukocyte cells was significantly higher in the WT mice 1 day after a treatment with TNFα than that in each of the other four groups of mice. No significant difference was found between these four other groups [27] . More strikingly, the percentages of eosinophils and neutrophils in the TNFα (1 day) group were >15 folds higher than that in naïve, Veh, TNFα (7 days), and TNF −/− +TNFα groups, and no significant difference was found in either eosinophils or neutrophils between these four other groups [27] .
Several inflammatory mediators and cytokines were selected in this study for measurements because their possible changes after the TNFα treatment were suggested in previous reports [2, 5, 30, 31] . BALF samples were collected for ELISA from separate groups of mice, and the results showed that the TNFα treatment significantly elevated the levels of leukotriene (LT) B4, LTC4/D4/E4, histamine, thromboxane B 2 and interleukin 1β in the BALF of WT mice, compared to that in the naïve, Veh and TNF −/− groups, and there was no significant difference in these inflammatory mediators and cytokine between these three other groups ( Fig. 1 ). However, we did not find any significant difference in the level of PGE 2 and IL-13 in BALF among all four groups. These measurements were not made in the TNFα (7 days) group. The total number of mice used in these groups varied: n = 10, 15, 15 and 5 in naïve, Veh, TNFα, and TNF −/− +TNFα groups, respectively. Due to the minimum BALF sample volumes required for various ELISA tests, certain assays (e.g., LTB 4 and IL-1β) were not performed in all 4 groups ( Fig. 1 ). Pentraxin 3 (PTX3), a member of the pentraxin superfamily of proteins that are involved in acute immunological responses to tissue injury [32] , was probably released in response to the surgical wound and needle puncture on the trachea during the intra-tracheal instillation of TNFα. There was no difference in the level of PTX3 between TNFα-and Veh-treated mice.
Some of these autacoids such as histamine, leukotrienes and thromboxanes [27] are known to exert potent stimulatory and/or sensitizing effects on vagal bronchopulmonary C-fiber afferents [11, 20] .
Hypersensitivity of vagal bronchopulmonary afferents to capsaicin induced by TNFα
To determine if the TNFα-induced inflammation can lead to the development of airway hypersensitivity, we studied the effect of TNFα treatment on vagal pulmonary afferents in young C57BL6/J mice [26] . TNFα and Veh were administered as described earlier. One to two days later, single-unit activities of vagal afferents were recorded from the sectioned right cervical vagus nerve in anesthetized, open-chest mice. Responses to both chemical (capsaicin) and mechanical (lung inflation and deflation) stimulations were studied in all three major types of vagal bronchopulmonary afferents that were identified based upon conventional criteria for classifications [11] : C-fibers, rapidly adapting receptors (RARs), and slowly adapting receptors (SARs). Action potentials generated from C-fiber endings are conducted in small-diameter non-myelinated afferent fibers, whereas those from RARs and SARs are carried in rapid-conducting large-diameter myelinated fibers. The general location of each receptor in the lung and airways was identified at the end of experiment.
An intravenous bolus injection of capsaicin (Cap, a selective agonist of TRPV1 [33, 34] ) triggered an abrupt (latency <1 s) and short-duration (3-5 s) of discharge in pulmonary Cfibers accompanied by bradycardia and hypotension (e.g., Fig. 2 ). The pulmonary C-fiber responses to both low (0.5 µg/kg) and high doses (1.0 µg/kg) of Cap were significantly higher in TNFα-treated mice than that in Veh-treated mice (Fig. 2 ). Pulmonary C-fibers were relatively insensitive to lung inflation, and the TNFα treatment did not increase the responses of pulmonary C-fibers to lung inflation.
In both Veh-and TNFα-treated mice, a large percentage of the RARs exhibited distinct phasic baseline activity that was synchronous with either expiratory or inspiratory phase of respiratory cycles. The remaining RARs had no detectable or very little respiratory-related baseline activity (e.g., Fig. 3 ). These two types of RARs were categorized as phasic RARs and silent RARs in this study. All of the SARs tested in this study exhibited distinct phasic baseline activity that reached a peak during either inspiratory or expiratory phase of the 
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In Veh-treated mice, injections of Cap did not cause significant stimulatory effect on silent RARs (e.g., Fig. 3A ). However, the responses of these silent RARs to Cap injections were elevated by >10 folds in TNFα-treated mice (Figs. 3B & 3C). Furthermore, the number of silent RARs that were activated by Cap injections, judged by the criterion that the increase in fiber activity was > 1.0 imp/s, was markedly higher in TNFα-treated mice: e.g., none of the 9 silent RARs tested were activated by the low dose of Cap (0.5 µg/kg) in the Veh group, whereas 6 of the 8 silent RARs were stimulated in the TNF group (Fig. 3D ). In contrast, there was no significant difference in the responses of silent RARs to either lung inflation (P>0.05) or deflation (P>0.05) between Veh-and TNFα-treated mice (Figs. 3E & 3F). In addition, the treatment with TNFα did not cause any potentiating effect on the responses to the same Cap injection, lung inflation and deflation in phasic RARs or SARs [26] .
It is well recognized that the afferent activity generated by these C-fiber endings plays an important role in eliciting the pulmonary defense reflexes in both healthy and disease conditions [11, 20] . Activation of these afferent endings by either inhaled chemical irritants or endogenous inflammatory mediators can generate respiratory sensations such as airway irritation and urge to cough [11] . In addition, it elicits powerful reflex responses including airway smooth muscle contraction, bronchial vasodilation and mucous hypersecretion mediated through the cholinergic reflex pathways [20, 35] . Intense and/or sustained stimulation of these afferents causes "neurogenic inflammation" in the tracheobronchial tree: extravasation of macromolecules and inflammatory cell chemotaxis, which involves the local "axonal reflex" and release of several potent bioactive tachykinins from these sensory endings [36, 37] . Thus, it seems logic to postulate that when the excitability of C-fiber afferents is enhanced by endogenous TNFα, these airway reflex responses to a given stimulus will be intensified.
After the TNFα treatment, a distinct sensitivity to Cap injection emerged in the silent RARs. This is an interesting finding because these receptors rarely exhibited any Cap sensitivity in control mice. However, very little information is available regarding the electrophysiological properties (e.g., conduction velocity, ion channels, etc.) and reflex functions of these silent RARs in mice. The firing behavior of these silent RARs exhibited certain features resembling the "high-threshold Aδ vagal afferents" described by Yu and coworkers [38] ; for example, they displayed a very mild sensitivity to Cap and other chemical stimulants of Cfibers (e.g., sulfur dioxide; data not shown). Based upon our observations in a follow-up cough study (described later), it is also possible that some of these RARs are the cough receptors that have been identified in other species [39, 40] .
Hypersensitivity of isolated pulmonary sensory neurons induced by TNFα
Because of the diverse actions of TNFα on a number of other target cells in the airways such as neutrophils, eosinophils and endothelial cells [5] , it was impossible to determine if the sensitizing effect is mediated through a direct action of TNFα on these neurons in a wholeanimal preparation. Therefore, this in-vitro study was carried out to determine the direct effect of TNFα in isolated mouse pulmonary sensory neurons [26] , using the Ca 2+ imaging technique [41] .
Pulmonary sensory neurons were isolated and cultured from the jugular-nodose ganglia complex in mice [21] , and identified by retrograde labeling with DiI, a fluorescent dye, as previously described [42] . The changes in the intracellular Ca 2+ concentration, [Ca 2+ ] i , in response to three concentrations of Cap (30, 100 and 300 nM) were measured in these neurons by the ratiometric method as described in our previous report [43] .
Two matching dishes of pulmonary jugular-nodose ganglia neurons isolated and cultured from the same mouse were incubated with vehicle (Veh group) and 50 ng/ml of TNFα (TNF group) in culture medium for 24 h. In the WT neurons incubated with TNFα, Cap challenge evoked a rapid and transient increase in the [Ca 2+ ] i in a concentration-dependent manner; this Cap-evoked increase in Ca 2+ ] i was significantly greater than that incubated with Veh, particularly at the higher concentrations of Cap (100 nM & 300 nM; Fig. 4 ). In another study series, the Cap-evoked response was markedly attenuated in the TNF −/− neurons when the responses of [Ca 2+ ] i to increasing concentrations of Cap were compared between pulmonary sensory neurons isolated from WT mice and TNF −/− mice after both groups of neurons were incubated with TNFα (50 ng/ml) for ~24 h. These results suggest the involvement of TNFR receptors in the TNFα-induced hypersensitivity of these neurons.
In an immunohistochemical study, we have previously demonstrated the presence of both TNFR1 and TNFR2 on the cell membrane of rat vagal pulmonary sensory neurons [44] . Activation of these TNFRs by TNFα can trigger several signaling pathways that are involved in a wide range of immunological responses and inflammatory reactions [45] [46] [47] . TNFα is initially produced as a membrane-anchored precursor protein, and subsequently cleaved into free proteins, which form biologically active homotrimers and interact with these TNFRs. Activation of TNFR1 is known to activate nuclear factor-kappa B [48] and mitogen activated protein kinases (MAPK) pathways, including the extracellular signal regulated kinase (ERK) [49] . Indeed, activation of p38 MAPK pathway increased TRPV1 expression in peripheral nociceptor neurons in a transcription-independent manner [50] . Furthermore, it has been shown that incubation of DRG neurons with TNFα for 24-48 h significantly increased the proportion of DRG neurons expressing TRPV1 receptor-like immunoreactivity via TNFR1 and the ERK activation [18] . Interestingly, a recent study has demonstrated the co-localization of TNFR1 and TRPV1 in the same DRG neurons in rats [16] .
Intracellular Ca 2+ is an important signal transduction molecule and plays a significant role in the regulation of neuronal membrane excitability, synaptic activity and neurotransmitter release [51, 52] . Transient changes in [Ca 2+ ] i are known to contribute to short-or long-term alterations in ion channels and gene expression, and can modulate the overall function of these afferents [53, 54] . Because Ca 2+ is one of the main ion species that is conducted through TRPV1, the TNFα-induced increase in Ca 2+ transient in response to Cap may result from an increase in the TRPV1 expression and/or excitability. On the other hand, the TNFαinduced sensitization of vagal C-fiber neurons should lead to a greater degree of subthreshold depolarization of the neuronal membrane and/or a larger number of action 
Author Manuscript
Author Manuscript potentials in response to a given level of chemical stimulation, which may in turn generate a higher level of Ca 2+ influx via voltage-dependent Ca 2+ channels [26] .
Cough hyperresponsiveness induced by TNFα in awake mice
One of the most important functions of these vagal bronchopulmonary afferents is to protect the lung and the rest of body against inhaled irritants and harmful gases in the environmental air. When the bronchopulmonary C-fibers are activated by irritant gases inhaled into the respiratory tract, it can trigger vigorous airway reflex responses such as cough, bronchoconstriction and airway secretion; these reflex responses can expel and/or reduce the penetration of these harmful gases into deeper regions of the lung. Furthermore, a subset of RARs have been identified and characterized as cough receptors in other species by previous investigators; these receptors are located in the extrapulmonary airways and quiescent during eupneic breathing [39, 40] . Based upon these background information, we hypothesized that the hypersensitivity of these afferents induced by TNFα elevated the cough responses to inhaled irritant gases in mice. We chose ammonia (NH 3 ) as the irritant gas to test this hypothesis because NH 3 is generated by nature as part of the nitrogen cycle in the environment, and is produced in large quantity for industrial use (e.g., agriculture fertilizers and household cleaning products); NH 3 at high concentrations (e.g., during occupational exposure or chemical accident) can cause lung injury and other detrimental health effects [55] .
TNFα and Veh were administered by i.t. instillation in two separate groups of young C57BL6/J mice as described earlier [27] , and cough responses to NH 3 inhalation challenges were measured on days 2, 3, 6 and 7 after the TNFα or Veh treatment. Because the cough reflex is suppressed by general anesthesia, this study was carried out in awake mice. The methodology was described in details in a recent report [28] . Briefly, during the experiment, mice moved freely in a plexiglass recording chamber (volume 160 ml). To prevent CO 2 accumulation and hyperthermia, room air was drawn through the chamber at a constant flow rate (200 ml/min) by a negative pressure. The pressure change in the chamber (P cham ), audio and video signals of the mouse movements were recorded simultaneously and used collectively for analyzing the cough frequency ( Fig. 5A ). Because breathing is inherently unstable in awake free-moving mice, the accuracy of the cough analysis was further verified by comparing with the changes of the intra-pleural pressure (P ip ) (e.g., Fig. 5A ), which was measured directly by surgically implanting the tip of a telemetry sensor in the intra-pleural space [28] .
The action of cough recorded in these mice consisted three distinct but tightly connected phases as characterized by the synchronized changes in both P cham and P ip : it was initiated by an inspiratory effort followed by a chest compression, and then a forced expiration that coincided with a weak but detectable cough sound. Expiratory reflex, similar to that described in other species [56, 57] , were also frequently found in awake mice; in comparison, the expiration reflex consisted only a chest compression, with no clear or significant preceding inspiratory effort, and followed by a forced expiration (Fig. 5B ). In addition, ~15% of the responses could not be easily distinguished between cough and expiration reflexes in our experiments [28] . Because both coughs and expiration reflexes are airway defense responses, they were pooled for data analysis in the evaluation of the overall cough responses in this study (Fig. 6 ).
In this study, the mouse was placed in the recording chamber for >30 min of adaptation period before each experiment. During the irritant gas inhalation challenge, ammonia (NH 3 ; 0.1% in air) was drawn into the chamber at the same flow rate as during baseline for 8 minutes; the cough frequency was analyzed for the 5-min baseline, 8-min challenge and 5min recovery in each animal. The cough frequency was near zero at the baseline (before the NH 3 inhalation challenge) in both Veh-and TNFα-treated mice, which did not change significantly after either Veh or TNFα treatment (Fig. 6 ). However, 48 h after the TNFα treatment, the cough frequency during the NH 3 inhalation challenge was elevated to more than five folds of that before the TNFα treatment, and the enhanced cough responsiveness to the NH 3 inhalation challenge persisted even after 7 days (Fig. 6) . In sharp contrast, there was no significant change in the cough response to NH 3 at any of these time points after the Veh treatment.
The cough reflex elicited by NH 3 of was probably elicited by activation of C-fibers and/or rapidly adapting receptors (RARs) located in the lung and airways [11, 22, 58] and/or tracheal cough receptors [40] . Indeed, using a single-fiber recording technique, we have shown that the NH 3 (0.1% concentration) inhalation challenge stimulated both these two types of vagal bronchopulmonary afferents in anesthetized mice (unpublished data). However, we cannot evaluate the relative role(s) of these different afferents in the TNFα-induced increase in cough response to inhaled NH 3 in this study. NH 3 has been shown to stimulate both TRPV1 and transient receptor potential ankyrine type 1 (TRPA1) receptors [59] . Both TRPV1 and TRPA1 receptors are ligand-gated non-selective cation channels [34] , and known to play important roles in the inflammation-induced hypersensitivity of vagal bronchopulmonary afferents [11, 12] . Our earlier studies have demonstrated that he same TNFα treatment induced pronounced airway inflammation and elevated sensitivities of both C-fibers and RARs in the lungs. Together, these results seem to suggest that the increased cough responses to NH 3 was caused by the TNFα-induced hypersensitivity of these bronchopulmonary afferents.
Conclusion
These studies demonstrated that intra-tracheal instillation of TNFα induced pronounced airway inflammation as illustrated by infiltration of eosinophils and neutrophils and the release of inflammatory mediators and cytokines in the lung and airways. Coinciding with the time of these changes, the TNFα treatment induced a distinct increase in the Cap sensitivity in vagal pulmonary C-fibers and silent RARs. Furthermore, the increased sensitivity to Cap was also present in the isolated pulmonary sensory neurons, suggesting that the sensitizing effect was mediated primarily through a direct action of TNFα on these neurons. Indeed, the same TNFα treatment also induced a lingering (> 7days) cough hyperresponsiveness to inhalation challenge of NH 3 in awake mice, further illustrating the heightening sensitivity of these bronchopulmonary afferents.
Stimulation of bronchopulmonary C-fiber afferents can also elicit bronchoconstriction and airway hypersecretion via the cholinergic reflex pathways [20, 35] ; intense stimulation can further generate neurogenic inflammation in the airways mediated through local axonal reflex mechanism [36, 37] . Hence, when the excitability of C-fiber afferents is enhanced by endogenous TNFα, these airway reflex responses to a given stimulus is expected to be intensified. The finding of the TNFα-induced hypersensitivity of bronchopulmonary C-fiber afferents in these studies may explain, at least in part, the airway hyperresponsiveness and inflammation caused by Inhalation of TNFα in healthy humans [10] .
Both the airway inflammation and the sensitizing effect on pulmonary sensory neurons caused by the TNFα treatment were abolished in the TNF −/− mice. These results further suggested the involvement of TNFR receptors. We believe that the activation of TNFRs by TNFα may activate several signaling pathways, trigger chemotactic actions, and enhance the release of inflammatory mediators and cytokines in the airways. Together, these TNFRsmediated actions may upregulate the sensitivity and/or expression of TRPV1 in the bronchopulmonary sensory nerves. Although the mechanism(s) underlying the potentiating effect of TNFα on these vagal bronchopulmonary sensory nerves is still not fully understood, these studies have established the evidence of this sensitizing effect of TNFα in mice, which should facilitate further investigations of the potential involvements of certain TNFR-mediated signaling pathways in transgenic and knockout mouse models. Pulm Pharmacol Ther. Author manuscript; available in PMC 2018 December 01.
